ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
9
views
0
references
Top references
cited by
94
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
1,177
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: A systematic review
Author(s):
Sachiko Ozawa
,
Andrew Mirelman
,
Meghan L. Stack
,
Damian G. Walker
,
Orin S. Levine
Publication date
Created:
December 2012
Publication date
(Print):
December 2012
Journal:
Vaccine
Publisher:
Elsevier BV
Read this article at
ScienceOpen
Publisher
PubMed
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Public health interventions that prevent mortality and morbidity have greatly increased over the past decade. Immunization is one of these preventive interventions, with a potential to bring economic benefits beyond just health benefits. While vaccines are considered to be a cost-effective public health intervention, implementation has become increasingly challenging. As vaccine costs rise and competing priorities increase, economic evidence is likely to play an increasingly important role in vaccination decisions. To assist policy decisions today and potential investments in the future, we provide a systematic review of the literature on the cost-effectiveness and economic benefits of vaccines in low- and middle-income countries from 2000 to 2010. The review identified 108 relevant articles from 51 countries spanning 23 vaccines from three major electronic databases (Pubmed, Embase and Econlit). Among the 44 articles that reported costs per disability-adjusted life year (DALY) averted, vaccines cost less than or equal to $100 per DALY averted in 23 articles (52%). Vaccines cost less than $500 per DALY averted in 34 articles (77%), and less than $1000 per DALY averted in 38 articles (86%) in one of the scenarios. 24 articles (22%) examined broad level economic benefits of vaccines such as greater future wage-earning capacity and cost savings from averting disease outbreaks. 60 articles (56%) gathered data from a primary source. There were little data on long-term and societal economic benefits such as morbidity-related productivity gains, averting catastrophic health expenditures, growth in gross domestic product (GDP), and economic implications of demographic changes resulting from vaccination. This review documents the available evidence and shows that vaccination in low- and middle-income countries brings important economic benefits. The cost-effectiveness studies reviewed suggest to policy makers that vaccines are an efficient investment. This review further highlights key gaps in the available literature that would benefit from additional research, especially in the area of evaluating the broader economic benefits of vaccination in the developing world. Copyright © 2012 Elsevier Ltd. All rights reserved.
Related collections
Vaccines
Author and article information
Journal
Title:
Vaccine
Abbreviated Title:
Vaccine
Publisher:
Elsevier BV
ISSN (Print):
0264410X
Publication date Created:
December 2012
Publication date (Print):
December 2012
Volume
: 31
Issue
: 1
Pages
: 96-108
Article
DOI:
10.1016/j.vaccine.2012.10.103
PubMed ID:
23142307
SO-VID:
39aa06eb-5337-4102-bcfa-055fbcc1c4bc
Copyright ©
© 2012
License:
https://www.elsevier.com/tdm/userlicense/1.0/
History
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
1,177
Association of Undernutrition and Neonatal, Infant and Under-5 Mortality: Evidence from 62 Low-Income and Middle-Income Countries
Authors:
Paddy Ssentongo
,
Joseph A. Lewcun
,
Anna E. Ssentongo
…
The Consumption Response to Seasonal Income: Evidence from Japanese Public Pension Benefits
Authors:
Takashi Unayama
,
Melvin Stephens
A social cost-benefit analysis of meat taxation and a fruit and vegetables subsidy for a healthy and sustainable food consumption in the Netherlands
Authors:
Marlin Broeks
,
Sander Biesbroek
,
Eelco A B Over
…
See all similar
Cited by
94
Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit–risk analysis of health benefits versus excess risk of SARS-CoV-2 infection
Authors:
Kaja M Abbas
,
Simon R. Procter
,
Kevin van Zandvoort
…
Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study
Authors:
Xiang Li
,
Christinah Mukandavire
,
Zulma Cucunubá
…
Face‐to‐face interventions for informing or educating parents about early childhood vaccination
Authors:
Rebecca Ryan
,
Louisa Walsh
,
Dell Horey
…
See all cited by
Version 1
- Current
Version 1